Treatment of Inoperable and/or Metastatic Biliary Tree Carcinomas With Single-Agent Gemcitabine or in Combination With Levofolinic Acid and Infusional Fluorouracil: Results of a Multicenter Phase II Study
- 15 October 2001
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (20), 4089-4091
- https://doi.org/10.1200/jco.2001.19.20.4089
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Chemotherapy with gemcitabine in patients with advanced gallbladder carcinomaZeitschrift für Gastroenterologie, 2000
- Biliary tract cancer: our experience with gemcitabine treatmentAnti-Cancer Drugs, 2000
- A phase II trial of 5‐fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaCancer, 1998
- A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaCancer, 1998
- Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule: Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)Cancer, 1996
- Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II studyAnnals Of Oncology, 1996
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal Of Cancer, 1995
- Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaAnnals Of Oncology, 1993